Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?

The aim of this paper is to consider the relative benefits of screening for type two diabetes mellitus in women with a previous pregnancy complicated by gestational diabetes mellitus. Recent studies suggest that women who experience GDM are at a greater risk of developing type 2 diabetes within 10–2...

Full description

Bibliographic Details
Main Authors: Gregory E. Rice, Sebastian E. Illanes, Murray D. Mitchell
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2012/721653
id doaj-886de1fea757410cae3468b6de331bd1
record_format Article
spelling doaj-886de1fea757410cae3468b6de331bd12020-11-24T23:23:07ZengHindawi LimitedInternational Journal of Endocrinology1687-83371687-83452012-01-01201210.1155/2012/721653721653Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?Gregory E. Rice0Sebastian E. Illanes1Murray D. Mitchell2The University of Queensland Centre for Clinical Research, RBWH Campus, Herston, Brisbane, QLD 4029, AustraliaDepartment of Obstetrics and Gynecology, Universidad de Los Andes, San Carlos de Apoquindo 2200, Las Condes, Santiago, ChileThe University of Queensland Centre for Clinical Research, RBWH Campus, Herston, Brisbane, QLD 4029, AustraliaThe aim of this paper is to consider the relative benefits of screening for type two diabetes mellitus in women with a previous pregnancy complicated by gestational diabetes mellitus. Recent studies suggest that women who experience GDM are at a greater risk of developing type 2 diabetes within 10–20 years of their index pregnancy. If considered as a stand-alone indicator of the risk of developing type 2 diabetes, GDM is a poor diagnostic test. Most women do not develop GDM during pregnancy and of those that do most do not develop type 2 diabetes. There is, however, a clear need for better early detection of predisposition to disease and/or disease onset to significantly impact on this global pandemic. The putative benefits of multivariate approaches and first trimester and preconception screening to increase the sensitivity of risk assignment modalities for type 2 diabetes are proposed.http://dx.doi.org/10.1155/2012/721653
collection DOAJ
language English
format Article
sources DOAJ
author Gregory E. Rice
Sebastian E. Illanes
Murray D. Mitchell
spellingShingle Gregory E. Rice
Sebastian E. Illanes
Murray D. Mitchell
Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?
International Journal of Endocrinology
author_facet Gregory E. Rice
Sebastian E. Illanes
Murray D. Mitchell
author_sort Gregory E. Rice
title Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?
title_short Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?
title_full Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?
title_fullStr Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?
title_full_unstemmed Gestational Diabetes Mellitus: A Positive Predictor of Type 2 Diabetes?
title_sort gestational diabetes mellitus: a positive predictor of type 2 diabetes?
publisher Hindawi Limited
series International Journal of Endocrinology
issn 1687-8337
1687-8345
publishDate 2012-01-01
description The aim of this paper is to consider the relative benefits of screening for type two diabetes mellitus in women with a previous pregnancy complicated by gestational diabetes mellitus. Recent studies suggest that women who experience GDM are at a greater risk of developing type 2 diabetes within 10–20 years of their index pregnancy. If considered as a stand-alone indicator of the risk of developing type 2 diabetes, GDM is a poor diagnostic test. Most women do not develop GDM during pregnancy and of those that do most do not develop type 2 diabetes. There is, however, a clear need for better early detection of predisposition to disease and/or disease onset to significantly impact on this global pandemic. The putative benefits of multivariate approaches and first trimester and preconception screening to increase the sensitivity of risk assignment modalities for type 2 diabetes are proposed.
url http://dx.doi.org/10.1155/2012/721653
work_keys_str_mv AT gregoryerice gestationaldiabetesmellitusapositivepredictoroftype2diabetes
AT sebastianeillanes gestationaldiabetesmellitusapositivepredictoroftype2diabetes
AT murraydmitchell gestationaldiabetesmellitusapositivepredictoroftype2diabetes
_version_ 1725565169710399488